fashion -WSS

fashion

author：leisure time 2025-10-01 23:01:05 - browse：18

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT wants to know your pick for a great summer read or listen

WSS

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Stanford president's case begs question: Who takes blame?

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Driven by the pandemic, applicants flood public health schools

explore

fashion

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Affordable Connectivity Program vital to health care, experts say

Anesthesiologist group: stop taking Ozempic before surgery

AstraZeneca lung cancer study comes in below expectations

Supreme Court strikes down use of affirmative action

Hubble vs. James Webb telescope images: See the difference

Medical leaders decry Supreme Court decision on affirmative action

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Duchenne breakthrough therapy leaves behind pioneering families

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

knowledge

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Security flaws in third

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Drug cartel violence flares in western Mexico after vigilante leader's killing

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

focus

focus

hotspot

knowledge